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he AAA-ATPase p97/Cdc48 functions in different
cellular pathways using distinct sets of adapters and
other cofactors. Together with its adaptor Ufd1–Npl4,
it extracts ubiquitylated substrates from the membrane for
subsequent delivery to the proteasome during ER-associated
degradation. Together with its adaptor p47, on the other
hand, it regulates several membrane fusion events, including
reassembly of Golgi cisternae after mitosis. The ﬁnding of a
ubiquitin-binding domain in p47 raises the question as to
whether the ubiquitin–proteasome system is also involved
T
 
in membrane fusion events. Here, we show that p97–p47-
mediated reassembly of Golgi cisternae requires ubiquitin,
but is not dependent on proteasome-mediated proteolysis.
Instead, it requires the deubiquitinating activity of one of
its cofactors, VCIP135, which reverses a ubiquitylation
event that occurs during mitotic disassembly. Together,
these data reveal a cycle of ubiquitylation and deubiqui-
tination that regulates Golgi membrane dynamics during
mitosis. Furthermore, they represent the ﬁrst evidence for a
proteasome-independent function of p97/Cdc48.
 
Introduction
 
p97/Cdc48 (in mammals also called VCP for valosin-
containing protein) is an essential AAA-ATPase that partici-
pates in a wide variety of cellular pathways using distinct
adapters and other cofactors (Woodman, 2003). These
pathways include ubiquitin- and proteasome-dependent
processing and degradation processes that are essential for
homeostasis and cell cycle progression (Weissman, 2001).
Its role is perhaps best illustrated during ER-associated
degradation, where, together with its adaptor Ufd1–Npl4, it
mediates the mobilization of ubiquitylated substrates into
the cytosol for delivery to the proteasome (Bays et al., 2001;
Ye et al., 2001; Braun et al., 2002; Jarosch et al., 2002).
Although mobilization or unfolding activity is likely involved
in all other p97/Cdc48-mediated processes, the extent to which
they involve ubiquitin and the proteasome is still unclear.
This question is particularly relevant to p97/Cdc48-
regulated membrane fusion events that reassemble fragmented
organelles after mitosis, including the nuclear envelope, the
ER, and the Golgi apparatus (Woodman, 2003). The best
characterized is reassembly of Golgi cisternae from dispersed
components at the end of mitosis. At least two pathways are
involved, one catalyzed by p97, the other by another AAA-
ATPase, N-ethylmaleimide–sensitive factor (NSF) (Shorter
and Warren, 2002). NSF uses the energy of ATP hydrolysis
to separate SNARE (soluble NSF attachment protein recep-
tor) complexes that form during membrane fusion, thereby
reactivating them for another round of fusion (Rothman,
1994; Jahn et al., 2003). However, NSF already completes
this process during mitotic fragmentation of the Golgi
apparatus, resulting in separated SNARE complexes on
mitotic membranes (Muller et al., 2002). This in turn indicates
the existence of additional regulatory mechanisms that are
needed during the reassembly process.
In the case of NSF-mediated fusion, this mechanism is
independent of ATP hydrolysis by NSF and involves the
ubiquitin-like protein GATE-16, which regulates SNARE
pairing (Muller et al., 2002). The functioning of p97, on the
other hand, depends on its adaptor p47, which links it to the
SNARE, syntaxin-5 (Rabouille et al., 1998). How this inter-
action regulates the formation of SNARE complexes that
lead to membrane fusion has, however, remained elusive.
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p47 also contains a ubiquitin-associated domain (UBA do-
main), which binds ubiquitin and is required for its activity
in Golgi reassembly (Meyer et al., 2002). This in turn sug-
gests (but does not prove) that ubiquitin is involved in p97-
mediated reformation of Golgi cisternae and raises questions
as to the role of ubiquitin in the process and whether this en-
tails proteasome-dependent proteolysis.
A second cofactor, VCIP135 (VCP[p97]/p47 complex–
interacting protein of 135 kD), was recently identified and
shown to be needed for p97–p47-mediated reassembly in
vitro and in vivo (Uchiyama et al., 2002). Both VCIP135
and p47 have ubiquitin homology domains that mediate
binding to p97. VCIP135 binds to the p97–p47–syntaxin-5
complex and can dissociate p97 and p47 from syntaxin-5
(Uchiyama et al., 2002). Although this observation clearly
suggests a very direct functional interaction between the
three proteins, it does not provide an explanation for the
role of VCIP135 in membrane fusion.
 
Results and discussion
 
Using database searches, we identified a region in the pep-
tide sequence of VCIP135 with homology to the catalytic
domains of two previously identified deubiquitinating en-
zymes, cezanne and A20 (Evans et al., 2003; Fig. 1 A). Im-
portantly, the catalytic cysteine residue is conserved at posi-
tion 218 in VCIP135. To test whether VCIP135, too, is a
deubiquitinating enzyme, we expressed it in bacteria along
with two variants that contained substitutions of the cata-
lytic cysteine with either alanine or serine (C218A and
C218S, respectively). We incubated VCIP135 and its vari-
ants with a mixture of in vitro–synthesized oligo-ubiquitin
chains (2–7 units, Ub2–Ub7). These chains serve as a sub-
strate for deubiquitinating enzymes that specifically cleave
the isopeptide bond between the units. Analysis of the
chains after incubation revealed that recombinant VCIP135
disassembled ubiquitin chains, thereby generating mono-
meric ubiquitin (Fig. 1 B, Ub1). The two mutants, on the
other hand, had no detectable activity. The addition of
ubiquitin-aldehyde, an inhibitor of deubiquitinating en-
zymes, significantly reduced chain disassembly by wt VCIP135,
indicating that its isopeptidase activity is indeed specific for
ubiquitin (Fig. 1 C).
Next, we tested the relevance of this activity in p97–p47-
mediated Golgi membrane fusion. The role of VCIP135 can
be monitored in vitro (Uchiyama et al., 2002). When mi-
totic Golgi fragments (MGFs) were salt treated, p97–p47
was no longer sufficient to promote fusion. Addition of ex-
ogenous VCIP135 restored this activity, indicating that en-
dogenous VCIP135 had been removed by the salt wash
(Uchiyama et al., 2002). We were able to reproduce this
published result in that salt treatment of MGFs reduced
p97–p47-mediated cisternal regrowth by 
 
 
 
80%, and read-
dition of recombinant VCIP135 restored fusion activity
back to 
 
 
 
80% of the value reached without salt treatment
(Fig. 2). The catalytically inactive mutants C218A and
C218S, on the other hand, were not able to restore the fu-
sion activity. C218S even inhibited compared with p97–p47
alone. These data show that the isopeptidase activity of
VCIP135 is required for its function in membrane fusion
Figure 1. VCIP135 is a deubiquitinating enzyme. (A) The peptide 
sequence of VCIP135 contains a region with homology to the catalytic 
domains of the deubiquitinating enzymes, cezanne and A20 (filled 
box). The highly conserved CYS and HIS boxes are aligned, and the 
catalytic cysteine (position 218 in VCIP135) and histidine residues 
are highlighted. The position of a ubiquitin homology domain in 
VCIP135 is also indicated (gray). (B) Recombinant wild-type (wt) 
VCIP135 and two variants in which the catalytic cysteine is changed 
to either alanine or serine (C218A and C218S, respectively) were 
generated in bacteria. A mixture of in vitro–synthesized ubiquitin 
chains with lengths of 2–7 units (Ub2–7) was incubated alone, with 
wt, or with mutant VCIP135, and then analyzed by Western blotting 
with antibodies against ubiquitin (top) and VCIP135 (bottom). (C) The 
reaction was performed as in B with wt VCIP135 in the absence ( ) 
or presence ( ) of 5  M ubiquitin-aldehyde (Ub-Al), an inhibitor of 
deubiquitinating enzymes.
Figure 2. The deubiquitinating activity of VCIP135 is required for 
p97–p47-mediated cisternal regrowth. Rat liver Golgi membranes 
were fragmented by treatment with mitotic HeLa cytosol, and MGFs 
were reisolated and washed with low or high salt (no salt wash or 
salt wash, respectively). MGFs were incubated with p97–p47 alone 
or in the presence of VCIP135 or its inactive mutants, and cisternal 
regrowth was quantitated. Results are presented as the mean per-
centage of membranes in cisternae ( SEM), where 0% represents 
incubations with buffer alone (26.7   3.1% of membrane in cister-
nae), and 100% represents MGFs incubated with p97–p47 (56.3   
3.2% of membrane in cisternae). Note that wt, but not mutant, 
VCIP135 could restore fusion activity after salt wash. 
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and suggest that the role of VCIP135 in the reformation of
Golgi cisternae from mitotic fragments is to remove ubiq-
uitin from a putative substrate in the membrane.
One can envision two ways as to how this might work.
VCIP135 could act antagonistically to a degradation pro-
cess. This has been described for deubiquitinating enzymes
such as HAUSP, which rescues the tumor suppressor p53
by removing ubiquitin moieties that would otherwise tar-
get it for degradation by the proteasome (Li et al., 2002;
Wing, 2003). Alternatively, ubiquitin could represent a
regulatory signal for membrane fusion that needs to be re-
moved by VCIP135 at a specific point during the reaction.
In this case, the process would resemble ubiquitin-depen-
dent membrane transport processes in the endocytic or
multivesicular body (MVB) pathways (Hicke and Dunn,
2003). Here, mono-ubiquitylation of substrates constitutes
a sorting signal that marks cargo for delivery to its final
destination. Transport is then mediated through interac-
tion with a series of ubiquitin-binding proteins. In the
MVB pathway, the final and obligatory step, however, in-
volves the removal of ubiquitin from the substrate by the
deubiquitinating enzyme Doa4p (Amerik et al., 2000; Du-
pre and Haguenauer-Tsapis, 2001; Katzmann et al., 2001;
Losko et al., 2001), a process that triggers sorting to the in-
ternal vesicles of the MVBs through a mechanism that is
still unclear.
In the case of Golgi reassembly, the results to date only
suggest a role for ubiquitin, as does the presence of a ubiq-
uitin-binding domain in p47. We therefore conducted ex-
periments to provide direct evidence. We reasoned that a
mutant of ubiquitin that could still be conjugated to sub-
strate proteins, but could not be recognized by p97–p47,
would act in a dominant-negative manner since it would be
linked to a putative substrate but then block processing by
p97 and its accessory factors. These properties have been
described in other pathways for a ubiquitin variant with a
substitution of isoleucine-44 to alanine (I44A) (Beal et al.,
1996; Sloper-Mould et al., 2001). We first confirmed that
binding of p97–p47 to ubiquitin is indeed abolished by this
mutation. Recombinant p97–p47 complex was incubated
with immobilized GST fused to ubiquitin that either repre-
sented the wt or the I44A form. Analysis of proteins bound
to the two variants revealed that the I44A substitution al-
most completely abolished binding of p97–p47 to ubiq-
uitin (Fig. 3 A).
We then studied the effect of the I44A ubiquitin variant
on the Golgi system in two ways. First, we added wt or I44A
ubiquitin to the mitotic cytosol that was used for the disas-
sembly of the membranes, reisolated the membranes, and
then performed the reassembly in the absence of exogenous
ubiquitin with either interphase cytosol or pure p97–p47. In
a second approach, we performed the disassembly under
normal conditions and added the exogenous ubiquitin vari-
ants during the reassembly step, to either interphase cytosol
or p97–p47. In both cases, the extent of Golgi disassembly
and subsequent reassembly of cisternae was determined by
stereological analysis of EM images. In these experiments,
addition of exogenous VCIP135 was not required because
the membranes were not salt washed. Furthermore, since the
assay relied on physical removal of soluble mitotic regula-
tors, such as cyclin B, that need to be degraded in vivo, this
allowed us to look exclusively at the processes occurring on
the membrane.
The addition of mutant ubiquitin had a dramatic effect
but only when added during disassembly, not reassembly.
The ability of interphase cytosol to stimulate reassembly de-
creased by 
 
 
 
50%, and the activity of p97–p47 was reduced
by 
 
 
 
75%, compared with membranes fragmented in the
presence of wt ubiquitin (Fig. 3 B). The fragmentation itself
was only slightly affected. On the other hand, the addition
of either the wt or the I44A variant to the reassembly reac-
Figure 3. Ubiquitylation during mitotic Golgi fragmentation is 
required for post-mitotic reformation of Golgi cisternae. (A) A 
ubiquitin-GST fusion protein (Ub-GST, wt) and its isoleucine-44 to 
alanine variant (I44A) were immobilized and incubated with recom-
binant p97–p47 complex. The beads were isolated, and bound 
protein was analyzed by Western blotting together with 5% of the 
input p97–p47. (B) Golgi membranes were fragmented in the absence 
or presence of 20  M exogenous recombinant ubiquitin (Ub[wt]) or 
the binding-deficient mutant thereof (Ub[I44A]). Membranes were 
then reisolated and either fixed ( ) or incubated with either interphase 
cytosol (int. cyt.) or p97–p47, and cisternal regrowth was determined. 
Results are presented as mean percentage ( SEM), where 0% 
represents mitotic Golgi fragments that were treated with mitotic 
cytosol plus Ub (wt) and then fixed (25.0   1.0% of membrane in 
cisternae), and 100% the same membranes reassembled in interphase 
cytosol (63.7   0.8% of membrane in cisternae). (C) Golgi membranes 
were fragmented without exogenous ubiquitin. Membranes were 
reisolated, split into different reactions, and either fixed ( ) or 
reassembled with either interphase cytosol or p97–p47, in the absence 
(none) or presence of exogenous Ub(wt) or Ub(I44A). The extent of 
cisternal regrowth was determined as in B. 
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tion of normally fragmented mitotic membranes did not af-
fect cisternal regrowth (Fig. 3 C).
We next explored the role of the proteasome in the pro-
cess. We first asked whether ubiquitin chains with the
lysine-48 linkage that direct substrates to the proteasome
were involved. We fragmented Golgi membranes in the
presence of I44A or ubiquitin variants that had specific
lysine-to-arginine mutations (K48R or K63R) to inhibit
chain extension. Whereas the I44A mutant again inhibited
subsequent Golgi reformation, neither K48R nor even
K63R, which inhibits lysine-63 chains involved in certain
proteasome-independent pathways, had any effect (Fig. 4
A). We then performed a series of experiments in the pres-
ence or absence of the proteasome inhibitors epoxomicin
(Fig. 4 B) or MG132 (not depicted) during disassembly
and/or reassembly with either interphase cytosol or p97–
p47. The solvent used for these inhibitors, DMSO, was
used as the control. Neither inhibitor had any effect on any
step of the reaction, showing that mitotic Golgi disassem-
bly–reassembly was proteasome independent. Lastly, we
wanted to clarify the function of the deubiquitinating activ-
ity of VCIP135 in relation to the proteasome. If VCIP135
acted in removing ubiquitin from a crucial factor in or-
der to rescue it from degradation by the proteasome, it
would only be needed if the proteasome was functional.
VCIP135 was, therefore, removed from MGFs by salt wash-
ing (swMGFs), and the effect of proteasome inhibitors was
then tested. As shown in Fig. 4 C, the addition of protea-
some inhibitors in the absence of VCIP135 did not restore
cisternal regrowth. VCIP135 was essential and unaffected
by the presence of either inhibitor. This shows that the
function of VCIP135 cannot be bypassed by inhibiting the
proteasome. VCIP135, therefore, plays an integral role in
p97–p47-mediated reassembly.
These data directly show that ubiquitin is required for the
mitotic Golgi cycle but in a proteasome-independent man-
ner. Furthermore, they indicate that a critical ubiquitylation
step occurs during mitotic fragmentation of the Golgi appa-
ratus. This has important implications for our understand-
ing of the dynamics. It means that the ubiquitin conju-
gate that is generated during fragmentation remains stable
throughout mitosis until it is specifically recognized and
processed by p97–p47 and VCIP135. This is best explained
by the fact that the activity of p97–p47 is mitotically regu-
lated (Uchiyama et al., 2003). Cdk1-mediated phosphoryla-
tion of p47 at the onset of mitosis removes the complex
from the membrane. Dephosphorylation in telophase then
allows rebinding and consequent processing of a substrate
on the membrane. This temporal separation of ubiquityla-
tion and processing is different from the mobilization step
that is mediated by p97 and its adaptor Ufd1–Npl4 during
ER-associated degradation. Here, ubiquitin modification of
the substrate and its mobilization are directly coupled, since
efficient ubiquitylation is dependent on the ATPase activity
of p97 (Ye et al., 2003).
Together, our findings show that the reaction mediated by
p97 and its adaptor p47 is very different from that mediated
by Ufd1–Npl4. The temporal separation of ubiquitylation
and processing, and the fact that the deubiquitinating activ-
ity of VCIP135 is required, but not the proteasome, indicate
that the ubiquitin modification in this pathway is not just an
intermediate on the way to the proteasome, but constitutes
a regulatory signal as in ubiquitin-dependent membrane
transport and other nondegradative pathways (Schnell and
Hicke, 2003). This is supported by our previous observation
that p47 preferably binds mono-ubiquitin, which usually
serves as a regulatory signal, whereas Ufd1–Npl4 binds
Figure 4. The mitotic Golgi disassembly–reassembly cycle is 
proteasome independent. (A) Golgi membranes were disassembled 
with mitotic cytosol as in Fig. 3 B in the absence or presence of the 
ubiquitin variants wt, K48R, K63R, or I44A. They were then reisolated 
and either fixed ( ) or reassembled with either interphase cytosol 
(int. cyt.) or p97–p47 as indicated. Cisternal regrowth is presented as 
mean percentage of membranes in cisternae (0% represents 24.7   
0.5%, 100% represents 60.7   2.5% in cisternae). Note that reas-
sembly was reduced only when I44A was added to the disassembly 
incubation. (B) Golgi membranes were disassembled with mitotic 
cytosol in the presence of the proteasome inhibitor epoxomicin 
(EPOX, 10  M) or its solvent, DMSO, as a control. Isolated mitotic 
membranes were then reassembled with either interphase cytosol 
(int. cyt.) or p97–p47, again in the presence or absence of EPOX 
(0% represents 27.0   1.2%, 100% represents 61.7   1.8% of 
membranes in cisternae). (C) MGFs were salt washed (swMGFs) to 
remove VCIP135 as in Fig. 2 and then either fixed ( ) or reassembled 
with p97–p47. Reassembly was performed with either p97–p47 alone 
(none) or together with VCIP135, MG132, EPOX, or combinations 
as indicated (0% represents swMGFs with 25.3   1.3% membranes 
in cisternae, 100% represents swMGF reassembled by p97–p47–
VCIP135 with 53.5   1.3% in cisternae). Note that the proteasome 
inhibitors did not substitute for the activity of VCIP135. 
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lysine-48 linked poly-ubiquitin chains, which direct proteins
to the proteasome (Meyer et al., 2002; Ye et al., 2003).
Exactly how ubiquitylation and deubiquitination regulate
Golgi dynamics remains to be shown. The intimate interac-
tion of the three factors, however, suggests a mechanism that
is dependent on the recognition and processing of a ubiq-
uitin conjugate by p97–p47 and subsequent deubiquitina-
tion by VCIP135. It is tempting to speculate that the target
in this pathway is part of the fusion machinery that includes
SNAREs and SNARE binding proteins. Ubiquitylation of
one or more of these proteins could serve as a recruitment
signal for p97–p47 that is then removed by VCIP135, leav-
ing the p97–p47 complex to act on the SNAREs. Alterna-
tively, ubiquitin could act, directly or indirectly, in inhibit-
ing SNARE function. The crucial step would then be its
removal by VCIP135, a process that may require the assis-
tance of p97–p47. The exact mechanism, however, can only
be clarified once the ubiquitylated targets are identified.
 
Materials and methods
 
Cloning, expression, and purification of VCIP135
 
VCIP135 was identified as a protein in rat liver cytosol that bound specifi-
cally to p97 and comigrated with Ufd2 (Meyer et al., 2000). It was cloned
based on data obtained by mass spectrometry (GenBank/EMBL/DDBJ ac-
cession no. AF289091). The open reading frame was inserted into pTrcHis
(Invitrogen) to generate a prokaryotic expression construct for 6xHis-
tagged VCIP135, equivalent to the one used by Uchiyama et al. (2002).
Mutations were introduced by changing the codon cysteine-218 to alanine
or serine (C218A and C218S, respectively) using the Stratagene Quick-
change method followed by confirmation of the entire sequence. Wt and
variants were expressed in 
 
E
 
s
 
cherichia
 
 
 
coli
 
 and purified in parallel as fol-
lows. Cells were lysed in buffer A (300 mM KCl, 50 mM Tris, pH 7.4, 2
mM 2-mercaptoethanol, 5% glycerol, 20 mM imidazole, 0.1 mM PMSF).
The proteins were isolated using Ni-agarose (QIAGEN) and desalted into
buffer B (150 mM KCl, 50 mM Hepes, pH 7.4, 1 mM DTT, 5% glycerol).
For the Golgi fusion assay, proteins were further purified by gel filtration
(Superdex 200; Amersham Biosciences) in buffer B. Aliquots were frozen
in liquid nitrogen and stored at 
 
 
 
80
 
 
 
C.
 
Expression and purification of other proteins
 
p97 was purified from rat liver cytosol. Recombinant p97, p47, and Ub-
GST were generated in bacteria, and binding experiments were performed
as previously described (Meyer et al., 2002). The mutations in ubiquitin
were introduced by the Quickchange method and the sequence con-
firmed. Recombinant ubiquitin and variants were expressed in the 
 
E. coli
 
strain BL21(DE3) codon
 
 
 
RIL (Stratagene). Cleared lysates were adjusted to
3.5% perchloric acid, and precipitated protein was removed by centrifuga-
tion. Ubiquitin was isolated from neutralized supernatants by cation-
exchange chromatography.
 
Deubiquitination assay
 
VCIP135 or its variants (2 
 
 
 
g each) were incubated with 0.5 
 
 
 
g of a mix-
ture of oligo-ubiquitin chains (Affiniti UW8860) in 20 
 
 
 
l buffer (150 mM
KCl, 50 mM Hepes, pH 7.4, 10 mM DTT, 5% glycerol, 0.01% Triton
X-100) for 60 min at 30
 
 
 
C. Aliquots of the reaction were analyzed by
Western blotting using an anti-ubiquitin antibody (Zymed Laboratories)
and an anti-VCIP135 serum raised in rabbits against GST-VCIP135 (amino
acids 870–1221). Ubiquitin-aldehyde was purchased from Calbiochem.
 
Golgi reassembly assay
 
The Golgi reassembly assay was performed as described previously
(Rabouille et al., 1995). In brief, rat liver Golgi was fragmented using cyto-
sol from mitotic HeLa cells. MGFs were isolated and soluble factors re-
moved by centrifugation through a 0.4 M sucrose cushion. When salt
washes were applied, MGFs were incubated for 30 min in 1 M KCl and
then recovered by centrifugation. For the reassembly step, membranes
were incubated for 60 min at 37
 
 
 
C with either HeLa interphase cytosol or
preformed complexes of p97 (100 ng/
 
 
 
l) and p47 (25 ng/
 
 
 
l). VCIP135 or
mutants thereof were added at 30 ng/
 
 
 
l where indicated. Samples were
fixed and processed for EM, and cisternal regrowth was quantitated as pre-
viously described (Rabouille et al., 1995). Recombinant ubiquitin variants
were added at 20 
 
 
 
M where indicated. MG132 and epoxomicin were
from Calbiochem and used at 100 and 10 
 
 
 
M, respectively.
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